Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
about
Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Serine protease inhibitor Kaza ...... the MEK/ERK signaling pathway.
@en
Serine protease inhibitor Kazal type 1
@nl
type
label
Serine protease inhibitor Kaza ...... the MEK/ERK signaling pathway.
@en
Serine protease inhibitor Kazal type 1
@nl
prefLabel
Serine protease inhibitor Kaza ...... the MEK/ERK signaling pathway.
@en
Serine protease inhibitor Kazal type 1
@nl
P2093
P2860
P356
P1476
Serine protease inhibitor Kaza ...... the MEK/ERK signaling pathway.
@en
P2093
Chao Jie Gong
Da Dao Jing
Lun Gen Lu
P2860
P304
P356
10.1111/1751-2980.12486
P50
P577
2017-05-23T00:00:00Z